The Regenerative Medicine Promotion Act The Regenerative Medicine Promotion Act of 2011 (HR 1862) was introduced in the House of Representatives on May 12, 2011 by Reps. DeGette (D-CO) and Bilbray (R-CA). Major provisions of the bill include: creation of a multi-agency Regenerative Medicine Coordinating Council within the Department of Health & Human Services (HHS); establishing grant programs to accelerate the availability of life-saving regenerative medicine therapies and research tools; funding of critical regulatory research at the Food & Drug Administration (FDA); and a detailed assessment of federal activities in regenerative medicine as well as progress compared to national programs in other countries. You can read more about the legislation on the Legislative Priorities page or from the press release.
